Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Laboratory Developed Tests Market, by Application
1.4.2 Europe Laboratory Developed Tests Market, by Technology
1.4.3 Europe Laboratory Developed Tests Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.
Chapter 5. Europe Laboratory Developed Tests Market by Application
5.1 Europe Oncology Market by Country
5.2 Europe Genetic Disorders/Inherited Disease Market by Country
5.3 Europe Infectious & Parasitic Diseases Market by Country
5.4 Europe Endocrine Market by Country
5.5 Europe Immunology Market by Country
5.6 Europe Nutritional & Metabolic Disease Market by Country
5.7 Europe Cardiology Market by Country
5.8 Europe Mental/Behavioral Disorder Market by Country
5.9 Europe Pediatrics-specific Testing Market by Country
5.1 Europe Others Market by Country
Chapter 6. Europe Laboratory Developed Tests Market by Technology
6.1 Europe Molecular Diagnostics Market by Country
6.2 Europe Immunoassays Market by Country
6.3 Europe Hematology & Coagulation Market by Country
6.4 Europe Microbiology Market by Country
6.5 Europe Clinical Chemistry Market by Country
6.6 Europe Histology/Cytology Market by Country
6.7 Europe Flow Cytometry Market by Country
6.8 Europe Mass Spectroscopy Market by Country
6.9 Europe Others Market by Country
Chapter 7. Europe Laboratory Developed Tests Market by Country
7.1 Germany Laboratory Developed Tests Market
7.1.1 Germany Laboratory Developed Tests Market by Application
7.1.2 Germany Laboratory Developed Tests Market by Technology
7.2 UK Laboratory Developed Tests Market
7.2.1 UK Laboratory Developed Tests Market by Application
7.2.2 UK Laboratory Developed Tests Market by Technology
7.3 France Laboratory Developed Tests Market
7.3.1 France Laboratory Developed Tests Market by Application
7.3.2 France Laboratory Developed Tests Market by Technology
7.4 Russia Laboratory Developed Tests Market
7.4.1 Russia Laboratory Developed Tests Market by Application
7.4.2 Russia Laboratory Developed Tests Market by Technology
7.5 Spain Laboratory Developed Tests Market
7.5.1 Spain Laboratory Developed Tests Market by Application
7.5.2 Spain Laboratory Developed Tests Market by Technology
7.6 Italy Laboratory Developed Tests Market
7.6.1 Italy Laboratory Developed Tests Market by Application
7.6.2 Italy Laboratory Developed Tests Market by Technology
7.7 Rest of Europe Laboratory Developed Tests Market
7.7.1 Rest of Europe Laboratory Developed Tests Market by Application
7.7.2 Rest of Europe Laboratory Developed Tests Market by Technology
Chapter 8. Company Profiles
8.1 Neogenomics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Guardant Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Quest Diagnostics Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.5 SWOT Analysis
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segment and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bio-Rad laboratories, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Eurofins Scientific SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis
Unique Offerings 